Thus, in our practice, genetic diagnosis failed to diagnose 9/20 (diagnostic sensitivity of 45%) of those with biochemically proven quantitative C1-INH deficiency, while incautious interpretation of variants of unknown significance might risk false positives, reducing specificity of the test. The gene discussed is SERPING1; the disease is hyperinsulinemic hypoglycemia, familial, 4.